Related Experiment Video
Updated: Feb 12, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Gas Plasma Pre-treatment Increases Antibiotic Sensitivity and Persister Eradication in Methicillin-Resistant
Li Guo1, Ruobing Xu2, Yiming Zhao2
1State Key Laboratory of Electrical Insulation and Power Equipment, Center for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an, China.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of serious nosocomial infections, and recurrent MRSA infections primarily result from the survival of persister cells after antibiotic treatment. Gas plasma, a novel source of ROS (reactive oxygen species) and RNS (reactive nitrogen species) generation, not only inactivates pathogenic microbes but also restore the sensitivity of MRSA to antibiotics. This study further found that sublethal treatment of MRSA with both plasma and plasma-activated saline increased the antibiotic sensitivity and promoted the eradication of persister cells by tetracycline, gentamycin, clindamycin, chloramphenicol, ciprofloxacin, rifampicin, and vancomycin. The short-lived ROS and RNS generated by plasma played a primary role in the process and induced the increase of many species of ROS and RNS in MRSA cells. Thus, our data indicated that the plasma treatment could promote the effects of many different classes of antibiotics and act as an antibiotic sensitizer for the treatment of antibiotic-resistant bacteria involved in infectious diseases.
Insights
Gas plasma treatment re-sensitizes antibiotic-resistant bacteria like MRSA to common antibiotics. This approach aids in eradicating persistent bacterial cells, offering a new strategy against difficult-to-treat infections.
Area of Science:
- Microbiology
- Biophysics
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) causes significant hospital-acquired infections.
- Recurrent infections stem from antibiotic-tolerant persister cells surviving treatment.
- Novel strategies are needed to overcome antibiotic resistance.
Purpose of the Study:
- To investigate gas plasma's effect on MRSA antibiotic sensitivity.
- To determine if plasma treatment can eradicate MRSA persister cells.
- To explore the role of reactive oxygen and nitrogen species (ROS/RNS) in this process.
Main Methods:
- Sublethal treatment of MRSA with gas plasma and plasma-activated saline.
- Assessing changes in antibiotic sensitivity to various classes of antibiotics.
- Measuring ROS and RNS levels within MRSA cells post-treatment.
Main Results:
- Plasma treatment increased MRSA sensitivity to tetracycline, gentamycin, clindamycin, chloramphenicol, ciprofloxacin, rifampicin, and vancomycin.
- Plasma and plasma-activated saline promoted the eradication of MRSA persister cells.
- Short-lived ROS and RNS generated by plasma were identified as key mediators.
Conclusions:
- Gas plasma acts as an effective antibiotic sensitizer for MRSA.
- Plasma treatment promotes the elimination of antibiotic-tolerant persister cells.
- This approach offers a promising adjunctive therapy for antibiotic-resistant infections.
Related Concept Videos
Development of Antibiotic Resistance
Treatment Resistant Cancers
Antibiotic Selection
Kinetic Molecular Theory and Gas Laws Explain Properties of Gas Molecules
Gas Exchange and Transport
Gas Laws: Boyle's, Gay-Lussac, Charles', Avogadro's, and Ideal Gas Law

